This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
The following general overview of NRC's financial position and operations are presented on an accrual basis for comparability with the complete financial statements published on NRC's Web site.
Condensed Statement of Financial Position At End of Year (March 31, 2009) |
% Change | 2009 | 2008 |
---|---|---|---|
Assets | |||
Total Assets | (4 %) | 821,313 | 851,212 |
Total | (4 %) | 821,313 | 851,212 |
Liabilities | |||
Total Liabilities | 6 % | 329,943 | 310,397 |
Equity | |||
Total Equity | (9 %) | 491,370 | 540,815 |
Total | (4 %) | 821,313 | 851,212 |
Condensed Statement of Operations At End of Year (March 31, 2009) |
% Change | 2009 | 2008 |
---|---|---|---|
Expenses | |||
Total Expenses | 5 % | 899,430 | 852,988 |
Revenues | |||
Total Revenues | 1 % | 156,246 | 154,530 |
Net Cost of Operations | 6 % | 743,184 | 698,458 |
Revenue is important to NRC, not only as a means of financing its operating and capital expenditures, but also as an indication of the value that NRC provides to its clients and collaborators. NRC earned total revenues of $156 million in 2008-09, up slightly from $155 million earned in 2007-08. NRC's largest component of revenue results from the sale of goods and services, primarily consisting of research services provided to industry and academic clients ($66 million), with the remaining balance provided by the sale of goods and information products ($11.3 million), and NRC rights and privileges ($9.6 million).
NRC incurred total expenses of $899 million in 2008-09, up from $853 million in 2007-08. NRC's major expense components - salaries and employee future benefits ($463 million) and grants and contributions ($133 million) are most important to NRC representing 66% of total expenses. NRC's most significant cost driver, salaries and employee future benefits, accounts for the majority of the $46 million increase in total expenses. Salaries and employee future benefits increased to $463 million, representing 51% of total expenses.
The following tables are located on the Treasury Board Secretariat Web site:
NRC's Council provides strategic direction and advice to the President and monitors progress against strategic plans. The Minister of Industry can also consult the NRC Council for advice on matters affecting NRC and of importance to science and technology in Canada. It usually meets three times a year and has four standing committees: the Executive Committee, the Human Resources Committee and the Audit, Evaluation and Risk Assessment Committee, and the Finance Committee. The Council is chaired by the President of NRC and the other members are appointed by the Government of Canada for three-year terms. Current members are:
Pierre Coulombe,
President (and Chair of Council), National Research Council,
Ottawa, Ontario
Dennis Anderson,
Management Consultant,
Libau, Manitoba
Paul Clark,
Former Vice-President, Research and Technology, NOVA Chemicals Corporation,
Calgary, Alberta
Peter Frise,
Scientific Director and CEO, Auto 21, University of Windsor,
Windsor, Ontario
John Harker,
President, Cape Breton University,
Sydney, Nova Scotia
Margaret Lefebvre,
Executive Director, Canadian Association of Income Funds,
Montréal, Québec
Kellie Leitch,
Assistant Dean (External), Chief/Chair of Paediatric Surgery and Assistant Professor, Paediatric Orthopaedics, University of Western Ontario,
London, Ontario
Douglas MacArthur,
President, MacArthur Group, Inc.,
Charlottetown, Prince Edward Island
Eva Mah Borsato,
President, Intellectual Capital Corporation Inc.,
Edmonton, Alberta
Howard Tennant,
President Emeritus, University of Lethbridge,
Lethbridge, Alberta
Normand Tremblay,
Strategic Management Consultant, Normand Tremblay and Associates,
Montréal, Québec
Allan Warrack,
Professor of Business Emeritus, University of Alberta,
Edmonton, Alberta
David Wood,
Head of Finance and Corporate Development, Secretary and Treasurer, Celator Pharmaceuticals Inc.,
Vancouver, British Columbia